Engineered Biomimetic Nanocarriers: Advancing Intracellular Delivery of NanoMOFs
Ester Polo a
a Universidad Santiago de Compostela / Centro Singular de Investigación en Química Biológica y Materiales Moleculare
Materials for Sustainable Development Conference (MATSUS)
Proceedings of MATSUS Spring 2025 Conference (MATSUSSpring25)
Multifunctional microporous materials for advanced applications in materials science - #FunPorMat
Sevilla, Spain, 2025 March 3rd - 7th
Organizers: Pablo del Pino and Beatriz Pelaz
Invited Speaker, Ester Polo, presentation 440
DOI: https://doi.org/10.29363/nanoge.matsusspring.2025.440
Publication date: 16th December 2024

Overcoming biological barriers is essential for nanomedicines to reach their intended targets, requiring the exploration of "smarter" delivery nanosystems that can discern when and where to release specific compounds, thereby avoiding off-target effects. However, translating these concepts into clinical practice demands a deeper understanding of how synthetic nanomaterials interact with the complex biological environment.

Inspired by the natural interactions of cells, viruses, and exosomes within the body, biomimetic nanocarriers replicate the structure and functionality of cellular membranes. These carriers, designed using cellular components such as those from cancer cells, platelets, and macrophages, exhibit enhanced pharmacokinetics and tissue-specific targeting capabilities (Adv. Biosys, 2020, 4 (3), 1900260; J. Nanobiotechnol. 2022, 20, 538; J .Nanobiotechnol., 2024, 22 (1), 10).). Such nanocarriers can be programmed for a variety of specialized functions, including immune evasion, homotypic targeting, and direct cytosolic delivery via membrane fusion, bypassing traditional endo-lysosomal pathways. (J. Colloid Interface Sci. 2023, 648, 488-496; J. Colloid Interface Sci, 2024). The combination of engineered biomimetic coatings with nanosized metal-organic frameworks (nanoMOFs) represents a novel approach that integrates the homotypic targeting and fusogenic capabilities of cell-derived membranes with the high payload capacity of MOFs. This innovative system demonstrates efficient cellular internalization of therapeutic agents, reduced toxicity, and enhanced cytotoxic effects in both 2D cultures and 3D spheroid models. These findings highlight the system’s potential for precise drug delivery in cancer therapy and suggest opportunities to adapt this approach for various tumor types and therapeutic agents, advancing the field of precision nanomedicine.

© FUNDACIO DE LA COMUNITAT VALENCIANA SCITO
We use our own and third party cookies for analysing and measuring usage of our website to improve our services. If you continue browsing, we consider accepting its use. You can check our Cookies Policy in which you will also find how to configure your web browser for the use of cookies. More info